Cancer Research and Treatment

Blocking xCT and PI3K/Akt pathway synergized with DNA damage of Riluzole-Pt(IV) prodrugs for cancer treatment

Zhe Li, Xin Qiao, Xiao-Meng Liu, Shu-Hao Shi, Xin Qiao, Jing-Yuan Xu

European Journal of Medicinal Chemistry.2023; 250: 115233. CrossRef

Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study

Yu Mei, Xijia Feng, Tienan Feng, Min Yan, Zhenggang Zhu, Tian Li, Zhenglun Zhu

Frontiers in Pharmacology.2022;[Epub] CrossRef

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity

Roser Velasco, Montserrat Alemany, Macarena Villagrán, Andreas A. Argyriou

Journal of Personalized Medicine.2021; 11(7): 669. CrossRef

The Incidence of Oxaliplatin-Induced Peripheral Neurotoxicity at Khartoum Oncology Hospital: A Cross-Sectional Survey

Asia-Pacific Journal of Oncology Nursing.2020; 7(3): 266. CrossRef

Clinical pharmacology of oncology agents in older adults: A comprehensive review of how chronologic and functional age can influence treatment-related effects

Ginah Nightingale, Rowena Schwartz, Ekaterina Kachur, Brianne N. Dixon, Christine Cote, Ashley Barlow, Brooke Barlow, Patrick Medina

Journal of Geriatric Oncology.2019; 10(1): 4. CrossRef

Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial

Se Hoon Park, Jeeyun Lee, Tae Sung Sohn, Do Hoon Lim, Kyoung-Mee Kim, Ji Yeong An, Min Gew Choi, Jun Ho Lee, Jae Moon Bae, Sung Kim, Su Jin Lee, Seung Tae Kim, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang

Precision and Future Medicine.2019; 3(1): 24. CrossRef

Oxaliplatin-induced enteric neuronal loss and intestinal dysfunction is prevented by co-treatment with BGP-15

Rachel M McQuade, Vanesa Stojanovska, Rhian Stavely, Cara Timpani, Aaron C Petersen, Raquel Abalo, Joel C Bornstein, Emma Rybalka, Kulmira Nurgali

British Journal of Pharmacology.2018; 175(4): 656. CrossRef

Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients

Akie Watanabe, Chang Cheng Yang, Winson Y. Cheung

Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin‐induced peripheral neuropathy in Taiwanese patients with colorectal cancer

Shu‐Yi Hsu, Wen‐Shih Huang, Shu‐Hui Lee, Tsui‐Ping Chu, Yung‐Chang Lin, Chang‐Hsien Lu, Randal D. Beaton, Sui‐Whi Jane

European Journal of Cancer Care.2018; : e12976. CrossRef

Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review

Asia-Pacific Journal of Clinical Oncology.2017; 13(6): 345. CrossRef

Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy

Molecular Pain.2017; 13: 174480691771469. CrossRef

ALA-induced photodynamic effect on vitality, apoptosis, and secretion of vascular endothelial growth factor (VEGF) by colon cancer cells in normoxic environment in vitro

A. Kawczyk-Krupka, K. Sieroń-Stołtny, W. Latos, Z.P. Czuba, B. Kwiatek, M. Potempa, K. Wasilewska, W. Król, A. Stanek

Photodiagnosis and Photodynamic Therapy.2016; 13: 308. CrossRef

ALA-induced photodynamic effect on viability, apoptosis and secretion of S100 protein, secreted by colon cancer cells in vitro

Aleksandra Kawczyk-Krupka, Wojciech Latos, Magdalena Latos, Zenon P. Czuba, Aleksander Sieroń

Photodiagnosis and Photodynamic Therapy.2016; 15: 218. CrossRef

ALA-mediated photodynamic effect on apoptosis induction and secretion of macrophage migration inhibitory factor (MIF) and of monocyte chemotactic protein (MCP-1) by colon cancer cells in normoxia and in hypoxia-like conditions in vitro

Aleksandra Kawczyk-Krupka, Andrzej M. Bugaj, Wojciech Latos, Katarzyna Wawrzyniec, Piotr Oleś, Anna Mertas, Zenon Czuba, Wojciech Król, Karolina Sieroń-Stołtny, Aleksander Sieroń

Photodiagnosis and Photodynamic Therapy.2015; 12(1): 27. CrossRef

The long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy

Joanna E. Fardell, Janette Vardy, Lauren A. Monds, Ian N. Johnston

Behavioural Brain Research.2015; 291: 80. CrossRef

Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)

α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity

Lorenzo Di Cesare Mannelli, Barbara Tenci, Matteo Zanardelli, Paola Failli, Carla Ghelardini

Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran

Ali Shahriari-Ahmadi, Ali Fahimi, Mehrdad Payandeh, Masoud Sadeghi

Asian Pacific Journal of Cancer Prevention.2015; 16(17): 7603. CrossRef

Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients

R. Velasco, J. Bruna, C. Briani, A. A. Argyriou, G. Cavaletti, P. Alberti, B. Frigeni, M. Cacciavillani, S. Lonardi, D. Cortinovis, M. Cazzaniga, C. Santos, H. P. Kalofonos

Journal of Neurology, Neurosurgery & Psychiatry.2014; 85(4): 392. CrossRef

Chemotherapy-induced neuropathy: A comprehensive survey

Cancer Treatment Reviews.2014; 40(7): 872. CrossRef

Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study

A. Custodio, J. Moreno-Rubio, J. Aparicio, J. Gallego-Plazas, R. Yaya, J. Maurel, O. Higuera, E. Burgos, D. Ramos, A. Calatrava, E. Andrada, R. López, V. Moreno, R. Madero, P. Cejas, J. Feliu

Annals of Oncology.2014; 25(2): 398. CrossRef

Current Colorectal Cancer Reports.2014; 10(3): 303. CrossRef

Anti-Colorectal Cancer Chemotherapy-Induced Diarrhoea: Current Treatments and Side-Effects

Rachel M. McQuade, Joel C. Bornstein, Kulmira Nurgali

International Journal of Clinical Medicine.2014; 05(07): 393. CrossRef

Oxaliplatin Induced Neurotoxicity among Patients with Colorectal Cancer: Documentation in Medical Records—A Pilot Study

Jenny E. Drott, Hans Starkhammar, Sussanne Börjeson, Carina M. Berterö

Open Journal of Nursing.2014; 04(04): 265. CrossRef

Advanced age and liability to oxaliplatin-induced peripheral neuropathy:post hocanalysis of a prospective study

A. A. Argyriou, C. Briani, G. Cavaletti, J. Bruna, P. Alberti, R. Velasco, S. Lonardi, D. Cortinovis, M. Cazzaniga, M. Campagnolo, C. Santos, H. P. Kalofonos

European Journal of Neurology.2013; 20(5): 788. CrossRef

Neuropatia Periférica em Pacientes com Câncer Colorretal em Tratamento com Oxaliplatina

Helena Maria de Cerqueira Mathias, Maria Cecília Mathias Machado, Adriano Celso Rodrigues

Revista Neurociências.2013; 21(3): 435. CrossRef

Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients

Hong-Hee Won, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Jong-Won Kim, Soo-Youn Lee, Se Hoon Park

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients

A.A. Argyriou, R. Velasco, C. Briani, G. Cavaletti, J. Bruna, P. Alberti, M. Cacciavillani, S. Lonardi, C. Santos, D. Cortinovis, M. Cazzaniga, H.P. Kalofonos

Annals of Oncology.2012; 23(12): 3116. CrossRef

Neuroprotective effect of neurotropin on chronic oxaliplatin-induced neurotoxicity in stage II and stage III colorectal cancer patients: results from a prospective, randomised, single-centre, pilot clinical trial

R. X. Zhang, Z. H. Lu, D. S. Wan, X. J. Wu, P. R. Ding, L. H. Kong, Z. Z. Pan, G. Chen

International Journal of Colorectal Disease.2012; 27(12): 1645. CrossRef